The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia
Clinical trial NCT04261426 · UNKNOWN
Trial details
- NCT number
- NCT04261426
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-10
- Primary completion
- 2020-04-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.